Additional designation of dextromethrophan into psychotropic substance raising concerns
Published: 2003-09-22 07:00:00
Updated: 2003-09-22 07:00:00
Following the government's move to designate dextromethrophan as one of psychotropic substances from this October, a number of domestic pharmaceutical firms are now bracing for measures to boost their sales of cold remedies containing dextromethrophan in the months to come.
Pharmaceutical busi...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
